- Home
- Share
- Forum
- Ulcerative colitis Forum
- Living with ulcerative colitis
- EU approves Pfizer's Xeljanz for ulcerative colitis
Patients Ulcerative colitis
EU approves Pfizer's Xeljanz for ulcerative colitis
- 50 views
- 0 support
- 4 comments
All comments
Phil55
Yes I would like to try this new drug. How do I go about getting a prescription ?
regards phil
JosephineO
Community managerGood advisor
@Phil55 Hello,
You would have to go to your doctor and discuss it with them. They will be able to point you in the right direction.
Best of luck!
See the signature
Josephine, Community Manager
troykath2
Are there known side effects to this medication?
JosephineO
Community managerGood advisor
@troykath2 Hello,
I am unsure but perhaps there are some other members on here that know or you can ask your doctor next time you are in for an appointment.
See the signature
Josephine, Community Manager
Give your opinion
Members are also commenting on...
Living with ulcerative colitis
My treatment has been delayed because of the Coronavirus - What can I do?
Articles to discover...
24/07/2023 | News
Everything you need to know about digestive and urinary stomas!
12/07/2023 | Testimonial
Multi condition: “At present I am well, and I am trying to make the most of my life!”
19/05/2023 | Advice
Tips for living a better life with Crohn's disease and ulcerative colitis (UC)
12/02/2019 | Advice
Photo Testimonial: Irritable bowel syndrome prevents people from living
12/01/2016 | News
Crohn’s disease, ulcerative colitis tied to anxiety and depression
05/04/2019 | Advice
Photo Testimonial: Ulcerative colitis won't stop me from travelling
Medication fact sheets - patient opinions...
Subscribe
You wish to be notified of new comments
Your subscription has been taken into account
JosephineO
Community managerGood advisor
Pfizer’s tofacitinib citrate has become the first oral medication and Janus kinase inhibitor to be approved in the EU for adults with moderate to severe ulcerative colitis.
Silvio Danese, President of the European Crohn’s and Colitis Organisation (ECCO) Governing Board, said: “Until now, people living with moderately to severely active ulcerative colitis have not had an oral treatment available that can both induce and maintain steroid-free remission.”
EU approves Pfizer's Xeljanz for ulcerative colitis
Michael Osso, President and CEO of the Crohn’s & Colitis Foundation, said: “What works for one ulcerative colitis patient may not work for another and some struggle with ongoing symptoms. That is why it is so critical that our patients have different treatment options available to them. We are thrilled to have this new treatment option available to ulcerative colitis patients. Every new treatment provides new hope to our community.”
Xeljanz 2016 global sales were up 77% on the previous year and the product has been a successful drug for Pfizer in other indications. It is also approved in the EU for rheumatoid arthritis and psoriatic arthritis, and has been approved in over 45 countries for use as a second-line therapy for rheumatoid arthritis after failure of one or more disease-modifying antirheumatic drugs.
Original source: https://www.zenopa.com/news/482/eu-approves-pfizers-xeljanz-for-ulcerative-colitis
What do you think of this new devolpment? Would you be interested to try this new medication?